Literature DB >> 7785461

Expression of bone morphogenetic protein-6 messenger RNA in bovine growth plate chondrocytes of different size.

D E Carey1, X Liu.   

Abstract

Bone morphogenetic protein-6 (BMP-6) is an osteoinductive factor that may have a regulatory role in the terminal differentiation of chondrocytes. We investigated the expression of BMP-6 messenger RNA in freshly isolated newborn calf rib chondrocytes separated by density gradient centrifugation into five highly enriched subpopulations at different stages of maturation as assessed by cell size and alkaline phosphatase activity. Expression of BMP-6 mRNA was compared with expression of type II collagen mRNA and type X collagen mRNA using Northern analysis. Type X collagen mRNA expression increased with increasing cell size whereas type II collagen mRNA varied little with cell size. BMP-6 mRNA expression was highest in small cells and lowest in the largest cells, which were maximally expressing type X collagen mRNA. This suggests that up-regulation of the BMP-6 gene may precede chondrocyte hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7785461     DOI: 10.1002/jbmr.5650100310

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  8 in total

1.  Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen.

Authors:  D J Rickard; L C Hofbauer; S K Bonde; F Gori; T C Spelsberg; B L Riggs
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 2.  New developments in the pathogenesis of articular cartilage calcification.

Authors:  G A Karpouzas; R A Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 3.  Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine.

Authors:  Sarah Sundelacruz; David L Kaplan
Journal:  Semin Cell Dev Biol       Date:  2009-08       Impact factor: 7.727

4.  Exogenous heparin binds and inhibits bone morphogenetic protein 6 biological activity.

Authors:  Jelena Brkljacic; Martina Pauk; Igor Erjavec; Antonio Cipcic; Lovorka Grgurevic; Renata Zadro; Gareth J Inman; Slobodan Vukicevic
Journal:  Int Orthop       Date:  2013-01-10       Impact factor: 3.075

5.  Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes.

Authors:  M Enomoto-Iwamoto; M Iwamoto; Y Mukudai; Y Kawakami; T Nohno; Y Higuchi; S Takemoto; H Ohuchi; S Noji; K Kurisu
Journal:  J Cell Biol       Date:  1998-01-26       Impact factor: 10.539

6.  A murine osteosarcoma cell line with a potential to develop ossification upon transplantation.

Authors:  T Kusumi; T Nishi; M Tanaka; S Tsuchida; H Kudo
Journal:  Jpn J Cancer Res       Date:  2001-06

7.  Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriatic lesions.

Authors:  M Blessing; P Schirmacher; S Kaiser
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

8.  Lysophosphatidylcholine acyltransferase 4 is involved in chondrogenic differentiation of ATDC5 cells.

Authors:  Shirou Tabe; Hisako Hikiji; Wataru Ariyoshi; Tomomi Hashidate-Yoshida; Hideo Shindou; Takao Shimizu; Toshinori Okinaga; Yuji Seta; Kazuhiro Tominaga; Tatsuji Nishihara
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.